doctor has passed this test he or she is accepted to have the equivalent experience of a senior house officer who qualified in Britain. In fact, even before 1975 such doctors had to be assessed for professional competence and skill and English language by designated regional assessors for overseas medical graduates. Moreover, no such doctor would be accepted for any form of registration by the General Medical Council unless his parent medical school was recognised by the council.
The very fact that the same problem is now being faced by such doctors who are trained wholly in Britain, and that the ability to speak good English is not a condition for doctors who come from European countries, tends to suggest that the problem is discrimination because ofprejudice and nothing else. Indeed, only when the medical profession accepts that such discrimination exists will the necessary steps be taken to eradicate it.
M SHAUKAT ALI Greenwich District Hospital, London SE109HE
Potentially dangerous ampoule confusion SIR,-Dr Clifford Hawkins's letter (3 January, p 54). prompts me to mention another potentially lethal similarity between ampoules.
Atropine is often required during anaesthesia to correct a bradycardia. Multiple doses of suxamethonium, heavy hyoscine premedication followed by halothane anaesthesia, the oculocardiac reflex, or the use ofvecuronium or atracurium may all cause a bradycardia of less than 40 beats/min, when rapid treatment with atropine 0-3-0-6 mg intravenously may be indicated.
Most anaesthetic drug cupboards are arranged alphabetically, and thus atropine 0 5 or 0-6 mg/ml and adrenaline 1 in 1000, 1 ml tend to be close neighbours.
In my experience of 15 hospitals these drugs have come in identically styled beige packaging and identical glass ampoules. The printing on the ampoules is black in both cases, although the style is different. In an emergency it is still all too easy to pick up the wrong box and inject the wrong drug, with probable dire results.
In these circumstances a different printing style is insufficient safeguard. At present we decorate the adrenaline boxes copiously with red ink, but could not the labelling on the ampoules or, even better, the glass itself be coloured red? Such a precaution would not obviate the responsibility of the doctor to check the label but merely provide additional security in emergencies. They say that the cost of some anaesthetic drugs has risen at a faster rate than inflation, yet at the time the paper was being prepared for publication the cost of what has now become the standard inhalational anaesthetic agent in the United Kingdom, enflurane, has doubled, as has the price of the more rarely used agent isoflurane, resulting in a very large increase in our department's expenditure on volatile agents. Secondly, they point out that newer relaxants are more expensive than their older equivalents, but they have ignored the potential change in practice resulting from the introduction of a new intravenous induction agent. Studies undertaken at Lewisham Hospital when propofol was being evaluated for clinical use indicated that this was a unique induction agent, and after its release for general use it has become our preferred induction agent for day care. On a dose for dose basis it is roughly twice the price of thiopentone sodium.
Lewisham University Hospital has pursued a policy ofmaximum effective monitoring ofpatients during anaesthesia and now provides endtidal monitoring, blood pressure monitoring, and electrocardiographic monitoring at all anaesthetic sites in the hospital. However, pulse oximeter monitoring demonstrations have indicated that pulse oximetry is now mandatory for anaesthetic practice since it provides, non-invasively, an accurate analogue for arterial oxygen tension and arterial blood flow. To equip our department with satisfactory ear oximeters will require £30 000. We are undertaking a study on Adverse reaction monitoring using cohort identification SIR,-The spontaneous adverse reaction reporting scheme using yellow cards sent to the Committee on Safety ofMedicines (CSM) is generally accepted to be an effective and inexpensive method of surveillance. The scheme is essentially an early warning system which generates evidence that needs corroborating. Although more reports are being sent year by year, the use of the scheme by doctors still needs to be improved, as does the quality of the reports they submit. These reports provide the only realistic way of monitoring the entire range of medicines throughout their market lives.
Nevertheless, there is a real need for cost effective postmarketing surveillance schemes to augment the yellow card system. Such a scheme could, for example, be established within the health service by introducing integrated patient record linkage regionally or nationally; observers at any point within such a system could then relate the use of a medicine to one or more aspect of a patient's history-and this would certainly enhance the value of the yellow cards.
Other proposals have been suggested by the Grahame-Smith Working Party, including postmarketing surveillance of cohorts of 10000 patients. This does not go far enough, however, as such numbers could detect a risk only of the order of I in 1000. As most product licence applications for new chemical entities are already supported by data on about 3000 patients, the working party recommendations would be unlikely to increase the chance of detecting new hazards and certainly not by the order of sensitivity needed. Recent adverse reactions judged sufficient to cause the withdrawal of products have had considerably lower incidences than 1 in 10000 patients treated. Furthermore, the development of the Grahame-Smith postmarketing surveillance proposals would be expensive and so serve to divert resources away from the ultimate goal of record linkage, which admittedly would itself be expensive.
I suggest, therefore, the introduction of a cheaper interim measure which would involve the identifying of FPIO prescription forms for all marketed new chemical entities relating to, say, 50000 to 100000 patients. This would not be difficult as all such forms are sent to the Prescription Pricing Authority. Then, if the yellow card reports from doctors showed an association between an adverse reaction and a new chemical entity a special follow up form could be sent .to all the doctors who had prescribed this particular drug. Information would be requested on whether any of these patients had experienced the specific adverse reaction.
The use of this scheme of "cohort identification" would enable both the numerator and denominator to be obtained for any adverse reaction which the CSM chose to pursue. The sensitivity of the method would depend solely on the size of the cohort initially identified and the response of the prescribing doctors to the questions sent to them.
The When a side effect of a drug is suspected an adverse reaction after rechallenge is probable. The severity of the reaction, however, is unpredictable. The following two cases illustrate some problems related to rechallenge and the scientific necessity to confirm adverse reactions.
Case 1-In 1977-8 an excess of cases of leucopenia caused by rifampicin were detected in North Karelia: Rimapen caused 11 cases of leucopenia in 140 patients treated for tuberculosis (7-9%), a much higher incidence than normal (0-08%).' We decided to change the rifampicin preparation and prospectively study the frequency ofleucopenia with Rimactan. The study was intended for internal use at the department for pulmonary diseases and was carried out in 1979-80. One patient out of 132 developed leucopenia. Our conclusion was to go on using Rimactan. This policy, however, was not accepted by the medical director of the hospital, who emphasised that there was no published evidence of an excess of side effects of Rimapen. Under these circumstances I felt obliged to publish our observations to avoid further unnecessary adverse reactions. To ensure the part played by rifampicin in two uncertain cases of leucopenia I rechallenged the patients with daily rifampicin three and three and a halfyears after the suspected rifampicin induced leucopenias. One patient reacted with a 'flu like syndrome and subsequently with renal failure and haemolysis on the ninth day of rechallenge despite careful precautions and informed consent. The possibility of such a severe side effect had been estimated as practically non-existent on the basis of the only seven previous cases, of which most had occurred during intermittent treatment or irregular drug intake. Seven haemodialyses were required and renal function returned to normal in three months. The debasing of medicine in the Soviet Union SIR,-Those who have written on the above subject in your journal seem to have at least one thing in common: they are all against sin. The question, then, is not whether abuses have occurred in medicine in the Soviet Union but how we should respond to the situation. We can, and at times perhaps should, act as Old Testament prophets, denouncing evil when we see it. Sometimes, however, we may prefer to think ofourselves as a curious and variable mixture of saint and sinner and consider it to be more appropriate to sit down with our Soviet colleagues as equals and friends to discuss, among other things, what actions are unacceptable in medical practice. This method may be slow, but, as Dr A Haines has pointed out (17 January, p 180), it can produce results. I have been on two medical visits to the Soviet Union in recent years and each time have been impressed by the open, thoughtful, and courteous atmosphere in which our discussions were held. Certainly, there are great cultural differences between us, but these may be due as much to historical as political factors, as Ms Caroline White (13 December, p 1524) suggested. Is it not just possible that, were the Royal College of Psvchiatrists to explore these differences with its opposite number in the Soviet Union, it might prove more fruitful than pursuing its present policies?
Since Dr G A Low-Beer's letter was published (7 February, p 373) we have heard that a number of dissidents are being released. If our response to this action is generous and positive perhaps it may encourage the government of the Soviet Union to increase the pace of democratisation and strengthen the hand ofMr Gorbachev against those in the Soviet Union who feel threatened by his more liberal policies.
PHILIPPA M LUDLAM Edinburgh EH9 1AR
Doppler studies in the growth retarded fetus SIR,-Is it possible to go a stage further regarding the work of Dr G A Hackett and colleagues (3 January, p 13) and consider the part played by the abdominal para-aortic bodies, including the organs of Zuckerkandl, in the control of selective vasoconstriction in the hypoxic fetus? Why are these bodies clustered down the aorta and found (among other places) very close to the origin of the inferior mesenteric artery, near but less close to the superior mesenteric artery, and near the origins of the umbilical arteries? These bodies are mature and functioning in utero at a titne when the adrenal medulla, which will in due course be secreting mainly adrenaline, is immature. As Dr Hackett and coworkers state, in fetal hypoxia circulatory adjustments occur to protect the fetal brain, myocardium, and adrenal glands. The abdominal para-aortic bodies are obviously distal to the main arterial vessels to the brain and heart but also seem to be just distal to the main sources of arterial supply to the adrenal glands.
Do these very vascular but poorly innervated structures, which secrete noradrenalinein response to fetal hypoxia, release this catecholamine into the venous circulation, whenee it is distributed after passage through the-heart, or can these organs release noradrenaline directly into arteries or at least to affect nearby arteries? If noradrenaline can be secreted directly to affect the local arterial tree this would explain the Doppler findings in the aortas of some growth retarded fetuses and their increased risk of necrotising enterocolitis. The direct action of noradrenaline on the gut, causing smooth muscle relaxation and sphincter contraction, might also explain the troublesome abdominal distension and feed intolerance experienced by some growth retarded babies. 
